Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The antibiotic polymyxin B modulates P2X7 receptor function.

Davide Ferrari1, Cinzia Pizzirani, Elena Adinolfi

  • 1Department of Experimental and Diagnostic Medicine, Sections of General Pathology, University of Ferrara, Italy. dfr@unife.it

Journal of Immunology (Baltimore, Md. : 1950)
|September 24, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of P2RX7 functional SNPs on osteoblast cell phenotype, function and signalling- roles in bone homeostasis and osteogenesis.

Purinergic signalling·2026
Same author

Comparison of Proteomic Analysis of Cerebrospinal Fluid From Neurological Patients With and Without Amyotrophic Lateral Sclerosis.

Journal of neurochemistry·2026
Same author

Unveiling the molecular crosstalk between the purinergic P2X7 receptor and cannabinoid subtype 2 receptor in human microglial HMC3 cells: New insights for multitarget therapies in neuroinflammation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Rethinking hypercortisolism screening in obesity and diabetes: A systematic review and meta-analysis.

Metabolism: clinical and experimental·2026
Same author

Benzamide derivatives as allosteric ligands of the human and rat P2X7 receptor.

Purinergic signalling·2026
Same author

Skin Application of Inflammasome Inhibitor MCC950 Prevents Psoriasis-like Cutaneous Manifestations and Associated Systemic Inflammation.

Inflammation·2026

Polymyxin B (PMB) enhances P2X7 receptor responses to nucleotides, increasing cell permeability and death. This suggests PMB can potentiate P2X7-mediated effects, impacting immune cell studies and potential therapies.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Polymyxin B (PMB) is an antibiotic known for neutralizing bacterial lipopolysaccharide (LPS).
  • The P2X7 receptor (P2X7R) is involved in various cellular processes and immune responses.

Purpose of the Study:

  • To investigate the effect of Polymyxin B on P2X7 receptor-mediated responses.
  • To explore the potential of PMB in modulating P2X7R activity in different cell types, including cancer cells.

Main Methods:

  • Experiments were conducted on HEK293 and K562 cells transfected with P2X7 cDNA, as well as mouse and human macrophages.
  • The study examined B lymphocytes from chronic lymphocytic leukemia patients.
  • Cellular responses to nucleotide stimulation in the presence and absence of PMB were measured, including calcium influx, membrane permeabilization, and cytotoxicity.

Related Experiment Videos

Main Results:

  • Polymyxin B significantly potentiated nucleotide-mediated P2X7R stimulation across various cell types.
  • ATP-induced calcium influx, plasma membrane permeabilization, and cytotoxicity were markedly enhanced by PMB.
  • The synergistic effect was blocked by oxidized ATP (oATP) but not KN-62, confirming P2X7R involvement.
  • Cells lacking P2X7R were insensitive to the combined PMB and ATP treatment.
  • PMB did not adversely affect cell viability at the tested concentrations.

Conclusions:

  • Polymyxin B acts as a potent modulator of P2X7 receptor function.
  • The findings suggest caution when interpreting ATP-stimulated immune cell responses in the presence of PMB due to potential LPS contamination or direct P2X7R potentiation.
  • PMB could be a valuable tool for research involving P2X7R modulation and potentially in therapeutic strategies targeting P2X7R-expressing cells.